Evidence map›Paper›PMID 36278177›Full record

ArticleFrontiers in pharmacology2022

Yang Xiao, Chongqing Gao, Junru Wu, Jing Li, Lijuan Wang, Yang You, Tianqi Peng, Keke Zhang, Mingrong Cao, Jian Hong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Extract ofCurrent issues in molecular biology · 2025
    Article
  5. Article
  6. Biology · 2025
    Article
  7. Investigation of the effects ofFrontiers in pharmacology · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yang XiaoDepartment of Hepatological Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Chongqing GaoDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, China.
Junru WuDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, China.
Jing LiDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, China.
Lijuan WangDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, China.
Yang YouDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, China.
Tianqi PengDepartment of Hepatological Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Keke ZhangDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, China.
Mingrong CaoDepartment of Hepatological Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Jian HongDepartment of Hepatological Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Jinan University · CNFirst Affiliated Hospital of Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcoholic abuse and obesity are the most common lifestyle implications of chronic liver injury, and always act synergistically to increase the risk of mortality.

Indexed as

alcohol consumptionhigh-mobility group box1 (HMGB1)obesityperiplaneta americana extractions (PAEs)steatohepatitis

Identifiers

PMID36278177
PMCPMC9583885
OpenAlexW4300166866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.